Inhibition of interleukin-1 or -6 after myocardial infarction: pros, cons, and future perspectives

European Heart Journal - Cardiovascular Pharmacotherapy

29 March 2025
Organised by: Logo
ESC Journals CARDIOVASCULAR PHARMACOLOGY Acute Coronary Syndromes

ESC 365 is supported by